Ustekinumab for the treatment of psoriatic arthritis

被引：1
|
作者：
Chandler, David John [1 ]
Bewley, Anthony [2 ]
机构：
[1] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[2] Royal London Hosp, London E1 1BB, England
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2014年 / 7卷 / 02期
关键词：
biologics; cutaneous immunology; IL-12; IL-23; psoriasis; psoriatic arthritis; ustekinumab; TO-SEVERE PSORIASIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; INCREASED EXPRESSION; FIBROBLAST FUNCTION; PLAQUE PSORIASIS; TNF INHIBITION; GROWTH-FACTOR;
D O I：
10.1586/17512433.2014.888310
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Psoriatic arthritis occurs commonly in those with psoriasis and is associated with progressive joint destruction, physical disability, reduced quality of life and increased mortality. For many patients the currently available treatment options including the anti-TNF treatments are inadequate. Recent data suggest that ustekinumab can provide an effective treatment option in these patients. We discuss the role of ustekinumab in the treatment of psoriatic arthritis and highlight areas requiring further work.
引用
收藏
页码：111 / 121
页数：11
相关论文
共 50 条
  • [1] Ustekinumab for the treatment of psoriatic arthritis
    Wofford, Jay
    Menter, Alan
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (02) : 189 - 202
  • [2] A review of ustekinumab in the treatment of psoriatic arthritis
    Roberts, Janet
    O'Rielly, Darren D.
    Rahman, Proton
    [J]. IMMUNOTHERAPY, 2018, 10 (05) : 361 - 372
  • [3] The safety of ustekinumab for the treatment of psoriatic arthritis
    Lopez-Ferrer, A.
    Laiz, A.
    Puig, L.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (06) : 733 - 742
  • [4] Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
    Savage L.J.
    Wittmann M.
    McGonagle D.
    Helliwell P.S.
    [J]. Rheumatology and Therapy, 2015, 2 (1) : 1 - 16
  • [5] Ustekinumab for the treatment of psoriatic arthritis: an update
    Davari, Parastoo
    Leo, Michael S.
    Kamangar, Faranak
    Fazel, Nasim
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2014, 7 : 243 - 249
  • [6] Worsening of Psoriatic Arthritis After Ustekinumab Treatment
    Onsun, Nahide
    Yalcin, Burak
    Sallahoglu, Kadriye
    Rezvani, Aylin
    [J]. AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (03) : E381 - E382
  • [7] Stroke under treatment with ustekinumab for psoriatic arthritis
    Aboudiab, M.
    Andrejak, M.
    Husein, T.
    Goeb, V.
    [J]. REVUE NEUROLOGIQUE, 2019, 175 (04) : 271 - 272
  • [8] The use of ustekinumab in refractory treatment of psoriatic arthritis
    Vega-Villanueva, Karen
    Cortez-Bazan, Nathaly
    Alvarado-Molina, Angela
    [J]. REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (05) : 448 - 449
  • [9] Ustekinumab for psoriatic arthritis
    Cuchacovich, Raquel S.
    Espinoza, Luis R.
    [J]. LANCET, 2009, 373 (9664): : 605 - 606
  • [10] Ustekinumab: The "New Kid on the Block" in the Treatment of Psoriatic Arthritis
    Torres, Tiago
    Faria, Raquel
    [J]. DRUG DEVELOPMENT RESEARCH, 2015, 76 (08) : 428 - 431
12345